GROYX
Price
$67.40
Change
+$0.13 (+0.19%)
Updated
Sep 18 closing price
Net Assets
1.81B
PAMCX
Price
$90.91
Change
-$0.03 (-0.03%)
Updated
Sep 18 closing price
Net Assets
20.82B
Interact to see
Advertisement

GROYX vs PAMCX

GROYX vs PAMCX Comparison Chart in %
View a ticker or compare two or three
VS
GROYX vs. PAMCX commentary
Sep 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GROYX is a Hold and PAMCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 20.8B vs. GROYX (1.81B). GROYX (0.00) and PAMCX (0.00) have matching dividends . GROYX was incepted earlier than PAMCX: GROYX (22 years) vs PAMCX (26 years). PAMCX (1.02) is less costly to investors than GROYX (0.81). GROYX is a more actively managed with annual turnover of: 62.00 vs. PAMCX (31.50). PAMCX has a lower initial minimum investment than GROYX: PAMCX (2500) vs GROYX (1000000). GROYX annual gain was more profitable for investors over the last year : 2.85 vs. PAMCX (-6.24). GROYX return over 5 years is better than : -0.94 vs. PAMCX (-26.21).
GROYXPAMCXGROYX / PAMCX
Total Expense Ratio0.781.0276%
Annual Report Gross Expense Ratio0.811.0279%
Fund Existence22 years26 years-
Gain YTD17.075-0.121-14,130%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.81B20.8B9%
Annual Yield % from dividends0.000.00-
Returns for 1 year2.85-6.24-46%
Returns for 3 years55.05-2.02-2,731%
Returns for 5 years-0.94-26.214%
Returns for 10 years79.3522.29356%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGOUX21.680.02
+0.09%
Goldman Sachs Mid Cap Growth R6
FGDDX43.380.04
+0.09%
Fidelity Advisor® Dividend Growth A
JOHIX29.66-0.01
-0.03%
JOHCM International Select Institutional
SIPIX30.42-0.13
-0.43%
SEI Mid-Cap I (SIMT)
BRSUX16.86-0.08
-0.47%
MFS Blended Research Small Cap Eq R4